Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer9s disease. A systematic review. - Clegg,A.; Bryant,J.; Nicholson,T.; McIntyre,L.; De Broe,S.; Gerard,K.; Waugh,N. (Int J Technol Assess Health Care, 2002)